#1 picks to power your 2021 gains: ResMed, Merck & Co. and Alimentation Couche-Tard

Article Excerpt

For 2021, we have singled out three growth stocks that brighten your prospects for the year ahead. All three are in a strong position to weather the current wave of COVID-19. Each is also poised for solid gains as new vaccines help kick-start global economic growth. RESMED INC. $217.96 is a #1 Power Buy for 2021. The company (New York symbol RMD; TSINetwork Rating: Average) (www.resmed.com; Shares outstanding: 144.9 million; Market cap: $31.6 billion; Dividend yield: 0.7%) primarily makes and sells CPAP (nasal continuous positive airway pressure) medical devices. They are used to treat patients with sleep apnea and more. With each new machine ResMed sells, it acquires a potential long-term replacement-parts customer: the tubing, masks and so on need replacement several times a year. That provides steady, recurring revenue. Meanwhile, the company’s devices increasingly collect data from users about their machine use and sleeping patterns, and the effect that the machines have on their health. It then gives users feedback that coaches them on how best to use the…